Johnson & Johnson's robotic surgery device gets US FDA marketing authorization
- Posted on July 22, 2026
- By Business News Today
- 0 Views
- 1 min read
In brief
Generating AI summary…
Johnson & Johnson's robotic surgery device gets US FDA marketing authorization
Johnson & Johnson secured FDA marketing authorization for its robotic surgery device. This approval allows the company to enter the soft-tissue robotic surgery market. The Ottava robotic surgical system is now cleared for multiple general surgery procedures. The healthcare conglomerate will begin a U.S. commercial launch with select customers. Expansion into additional indications and regulatory markets is also planned.
